TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
TGF-β1 is a major player in chronic liver diseases promoting fibrogenesis and tumorigenesis through various mechanisms. The expression and function of TGF-β2 have not been investigated thoroughly in liver disease to date. In this paper, we provide evidence that TGF-β2 expression correlates with fibr...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 21, 2016
|
| In: |
OncoTarget
Year: 2016, Jahrgang: 7, Heft: 15, Pages: 19499-19518 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.6967 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.18632/oncotarget.6967 Verlag, kostenfrei, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=6967&path[]=19757 
|
| Verfasserangaben: | Anne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, Hanna Korhonen, Michel Janicot, Susanne N. Weber, Maria Thomas, Albrecht Piiper, Esther Bertran, Isabel Fabregat, Kerstin Abshagen, Jochen Hess, Peter Angel, Cédric Coulouarn, Steven Dooley, Nadja M. Meindl-Beinker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1662749015 | ||
| 003 | DE-627 | ||
| 005 | 20230426154237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190403s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.6967 |2 doi | |
| 035 | |a (DE-627)1662749015 | ||
| 035 | |a (DE-599)KXP1662749015 | ||
| 035 | |a (OCoLC)1341206058 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Dropmann, Anne |d 1986- |e VerfasserIn |0 (DE-588)1166622614 |0 (DE-627)103052047X |0 (DE-576)510831621 |4 aut | |
| 245 | 1 | 0 | |a TGF-β1 and TGF-β2 abundance in liver diseases of mice and men |c Anne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, Hanna Korhonen, Michel Janicot, Susanne N. Weber, Maria Thomas, Albrecht Piiper, Esther Bertran, Isabel Fabregat, Kerstin Abshagen, Jochen Hess, Peter Angel, Cédric Coulouarn, Steven Dooley, Nadja M. Meindl-Beinker |
| 246 | 3 | 3 | |a TGF-beta 1 and TGF-beta 2 abundance in liver diseases of mice and men |
| 264 | 1 | |c January 21, 2016 | |
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.04.2019 | ||
| 520 | |a TGF-β1 is a major player in chronic liver diseases promoting fibrogenesis and tumorigenesis through various mechanisms. The expression and function of TGF-β2 have not been investigated thoroughly in liver disease to date. In this paper, we provide evidence that TGF-β2 expression correlates with fibrogenesis and liver cancer development. Using quantitative realtime PCR and ELISA, we show that TGF-β2 mRNA expression and secretion increased in murine HSCs and hepatocytes over time in culture and were found in the human-derived HSC cell line LX-2. TGF-β2 stimulation of the LX-2 cells led to upregulation of the TGF-β receptors 1, 2, and 3, whereas TGF-β1 treatment did not alter or decrease their expression. In liver regeneration and fibrosis upon CCl4 challenge, the transient increase of TGF-β2 expression was accompanied by TGF-β1 and collagen expression. In bile duct ligation-induced fibrosis, TGF-β2 upregulation correlated with fibrotic markers and was more prominent than TGF-β1 expression. Accordingly, MDR2-KO mice showed significant TGF-β2 upregulation within 3 to 15 months but minor TGF-β1 expression changes. In 5 of 8 hepatocellular carcinoma (HCC)/hepatoblastoma cell lines, relatively high TGF-β2 expression and secretion were observed, with some cell lines even secreting more TGF-β2 than TGF-β1. TGF-β2 was also upregulated in tumors of TGFα/cMyc and DEN-treated mice. The analysis of publically available microarray data of 13 human HCC collectives revealed considerable upregulation of TGF-β2 as compared to normal liver. Our study demonstrates upregulation of TGF-β2 in liver disease and suggests TGF-β2 as a promising therapeutic target for tackling fibrosis and HCC. | ||
| 700 | 1 | |a Dediulia, Tatjana |d 1986- |e VerfasserIn |0 (DE-588)1182379443 |0 (DE-627)1662737386 |4 aut | |
| 700 | 1 | |a Breitkopf-Heinlein, Katja |d 1971- |e VerfasserIn |0 (DE-588)122473833 |0 (DE-627)705922375 |0 (DE-576)293287589 |4 aut | |
| 700 | 1 | |a Dooley, Steven |d 1960- |e VerfasserIn |0 (DE-588)1028589190 |0 (DE-627)73128951X |0 (DE-576)376074116 |4 aut | |
| 700 | 1 | |a Meindl-Beinker, Nadja M. |d 1975- |e VerfasserIn |0 (DE-588)124950159 |0 (DE-627)368960056 |0 (DE-576)294584757 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 7(2016), 15, Seite 19499-19518 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a TGF-β1 and TGF-β2 abundance in liver diseases of mice and men |
| 773 | 1 | 8 | |g volume:7 |g year:2016 |g number:15 |g pages:19499-19518 |g extent:20 |a TGF-β1 and TGF-β2 abundance in liver diseases of mice and men |
| 856 | 4 | 0 | |u https://doi.org/10.18632/oncotarget.6967 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=6967&path[]=19757 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190403 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 124950159 |a Meindl-Beinker, Nadja M. |m 124950159:Meindl-Beinker, Nadja M. |d 60000 |d 61100 |e 60000PM124950159 |e 61100PM124950159 |k 0/60000/ |k 1/60000/61100/ |p 16 |y j | ||
| 998 | |g 1028589190 |a Dooley, Steven |m 1028589190:Dooley, Steven |d 60000 |d 61100 |e 60000PD1028589190 |e 61100PD1028589190 |k 0/60000/ |k 1/60000/61100/ |p 15 | ||
| 998 | |g 122473833 |a Breitkopf-Heinlein, Katja |m 122473833:Breitkopf-Heinlein, Katja |d 60000 |d 61100 |e 60000PB122473833 |e 61100PB122473833 |k 0/60000/ |k 1/60000/61100/ |p 3 | ||
| 998 | |g 1182379443 |a Dediulia, Tatjana |m 1182379443:Dediulia, Tatjana |d 60000 |d 61100 |e 60000PD1182379443 |e 61100PD1182379443 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 1166622614 |a Dropmann, Anne |m 1166622614:Dropmann, Anne |d 60000 |d 61100 |e 60000PD1166622614 |e 61100PD1166622614 |k 0/60000/ |k 1/60000/61100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1662749015 |e 3417818052 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"20 S."}],"title":[{"title_sort":"TGF-β1 and TGF-β2 abundance in liver diseases of mice and men","title":"TGF-β1 and TGF-β2 abundance in liver diseases of mice and men"}],"person":[{"display":"Dropmann, Anne","family":"Dropmann","given":"Anne","role":"aut"},{"display":"Dediulia, Tatjana","family":"Dediulia","given":"Tatjana","role":"aut"},{"given":"Katja","role":"aut","family":"Breitkopf-Heinlein","display":"Breitkopf-Heinlein, Katja"},{"display":"Dooley, Steven","family":"Dooley","role":"aut","given":"Steven"},{"family":"Meindl-Beinker","role":"aut","given":"Nadja M.","display":"Meindl-Beinker, Nadja M."}],"recId":"1662749015","name":{"displayForm":["Anne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, Hanna Korhonen, Michel Janicot, Susanne N. Weber, Maria Thomas, Albrecht Piiper, Esther Bertran, Isabel Fabregat, Kerstin Abshagen, Jochen Hess, Peter Angel, Cédric Coulouarn, Steven Dooley, Nadja M. Meindl-Beinker"]},"origin":[{"dateIssuedDisp":"January 21, 2016","dateIssuedKey":"2016"}],"id":{"eki":["1662749015"],"doi":["10.18632/oncotarget.6967"]},"note":["Gesehen am 02.04.2019"],"titleAlt":[{"title":"TGF-beta 1 and TGF-beta 2 abundance in liver diseases of mice and men"}],"relHost":[{"title":[{"title_sort":"OncoTarget","title":"OncoTarget","subtitle":"open access impact journal"}],"language":["eng"],"pubHistory":["1.2010,Mai -"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 16.08.2018"],"part":{"issue":"15","year":"2016","pages":"19499-19518","volume":"7","extent":"20","text":"7(2016), 15, Seite 19499-19518"},"id":{"issn":["1949-2553"],"zdb":["2560162-3"],"eki":["63035975X"]},"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisher":"Impact Journals LLC"}],"disp":"TGF-β1 and TGF-β2 abundance in liver diseases of mice and menOncoTarget","recId":"63035975X"}]} | ||
| SRT | |a DROPMANNANTGF1ANDTGF2120 | ||